The particular focus of the partnership is to explore potential of small molecules to treat obesity
doi:10.1016/j.molmet.2014.04.009 305
and providing ingredients like ginger that have evidence for reducing nausea
Beneficiaries may need to meet requirements related to: Age Body mass index, or BMI A prescription for weight loss or maintaining weight reduction Use of the medication along with lifestyle modifications Other qualifying health conditions CMS guidance indicates that the program is designed for beneficiaries seeking GLP-1 medications solely to reduce excess body weight or maintain weight reduction
However, if you notice severe swelling, redness extending beyond 2 inches, fever, or trouble breathing, reach out to a healthcare provider right away
Administrative activation, clinician review, state coverage confirmation, and pharmacy acceptance each occur as separate checkpoints controlled by different parties